While miR-517a acts as an oncogene to promote glycolysis in HCC, miR-199a-5p and miR-885-5p suppress glucose consumption, lactate production, cell proliferation, and tumorigenesis in liver cancer cells by targeting HK2 [87,88,96]. The gene discussed is HK2; the disease is hepatocellular carcinoma.